drugset
drugset / Trial / NCT02131324

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

NCT02131324 ↗

Phase 2 Completed 50 enrolled Promius Pharma, LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the potential of DFD06 cream to suppress the HPA (hypothalamic-pituitary-adrenal) axis as compared to clobetasol propionate cream, 0.05% cream when applied twice daily for 15 days.

Timeline

Start
2014-05-08
Primary completion
2016-04
Completion
2016-08-11

Drugs

EvaluationDrugModalityDoseRoute
Subject clobetasol propionate Small molecule 0.025 % Topical
Subject clobetasol propionate Small molecule 0.05 % Topical

Indications

psoriasis